|
|
Article: GHRH analogue trims visceral fat in HIV study.(Infectious Diseases)(growth hormone-releasing hormone )
- Article from:
- Internal Medicine News
- Article date:
- May 1, 2007
- Author:
CopyrightCOPYRIGHT 2007 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LOS ANGELES -- Visceral adipose tissue declined by 15% in HIV patients treated for 26 weeks with a growth hormone-releasing hormone (GHRH) factor analogue, while visceral fat in patients assigned to placebo increased 5%, Dr. Steven Grinspoon reported at the 14th Conference on Retroviruses and Opportunistic Infections.
"This was a very potent effect, a net change of 20% versus placebo in 6 months," said Dr. Grinspoon, director of the Massachusetts General Hospital Program in Nutritional Metabolism in Boston.
An "emerging consensus" of data suggests that cardiovascular risk is substantially elevated in patients with HIV, underscoring the clinical ...